These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14285481)

  • 41. D-lysergic acid in the treatment of the biological features of childhood schizophrenia.
    Bender L
    Dis Nerv Syst; 1966 Jul; 7 Suppl(7):43-6. PubMed ID: 5965284
    [No Abstract]   [Full Text] [Related]  

  • 42. ANTAGONISM OF LYSERGIC ACID DIETHYLAMIDE (LSD)-INDUCED HYPERGLYCEMIA.
    ELDER JT
    Int J Neuropharmacol; 1964 Jul; 3():295-300. PubMed ID: 14333281
    [No Abstract]   [Full Text] [Related]  

  • 43. METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE.
    SOUTHWELL N; WILLIAMS JD; MACKENZIE I
    Lancet; 1964 Mar; 1(7332):523-4. PubMed ID: 14100184
    [No Abstract]   [Full Text] [Related]  

  • 44. THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
    NANDY K; SHANTHAVEERAPPA TR; BOURNE GH
    Acta Histochem; 1964 Apr; 17():259-67. PubMed ID: 14190338
    [No Abstract]   [Full Text] [Related]  

  • 45. [Action of serotonin (5-HT) and of one of its inhibitors, UML 491, on the development of granulomatous reactions in the rat].
    FRANCHIMONT P; VAN CAUWENBERGE H; LECOMTE J
    C R Seances Soc Biol Fil; 1961; 155():432-5. PubMed ID: 24545610
    [No Abstract]   [Full Text] [Related]  

  • 46. EXPERIMENTAL HYPERTHYROIDISM INDUCED BY CHRONIC LYSERGIC ACID BUTANOLAMIDE TREATMENT.
    MESS B; SZANTO L
    Acta Physiol Acad Sci Hung; 1964; 25():83-8. PubMed ID: 14196573
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 48. Serotonin antagonists and central hyperthermia produced by biogenic amines in conscious rabbits.
    Girault JM; Jacob JJ
    Eur J Pharmacol; 1979 Jan; 53(2):191-200. PubMed ID: 32059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. STUDIES ON BIOGENIC AMINES AND PSYCHOACTIVE DRUG ACTIONS, WITH SPECIAL REFERENCE TO LYSERGIC ACID DIETHYL AMIDE.
    SANKAR DV; BROER HH; CATES N; SANKAR DB
    Trans N Y Acad Sci; 1964 Jan; 26():369-76. PubMed ID: 14170548
    [No Abstract]   [Full Text] [Related]  

  • 50. Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials.
    Wilkison DM; Hosko MJ
    Exp Neurol; 1983 Nov; 82(2):391-403. PubMed ID: 6628626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [ACTION OF 5-HYDROXYTRYPTAMINE AND ITS ANTAGONISTS ON THE VASOMOTOR CENTERS].
    SCHMITT H; SCHMITT H
    Arch Int Pharmacodyn Ther; 1964 Sep; 151():217-24. PubMed ID: 14205415
    [No Abstract]   [Full Text] [Related]  

  • 52. [STUDY OF THE EFFECT OF SEROTONIN ON RENAL CORTICAL NECROSIS CAUSED BY HORMONES].
    SZARVAS F; KOVACS K
    Kiserl Orvostud; 1964 Apr; 16():198-202. PubMed ID: 14155569
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of serotonin, of one of its inhibitors (UML 491) and of glucagon on experimental osteolathyrism in the rat].
    FRANCHIMONT P; LEFEBVRE P; VAN CAUWENBERGE H
    C R Seances Soc Biol Fil; 1961; 155():427-31. PubMed ID: 24545609
    [No Abstract]   [Full Text] [Related]  

  • 54. ANTI-SEROTONIN ACTIVITY AND CLINICAL TRANQUILIZATION.
    GALLANT DM; BISHOP MP; STEELE CA; NOBLIN CD
    J Neuropsychiatr; 1964 Jun; 5():273-8. PubMed ID: 14171300
    [No Abstract]   [Full Text] [Related]  

  • 55. [CLINICAL TEST IN ALLERGIC PATIENTS WITH A NEW ANTISEROTONIN DRUG].
    ZARATE O; QUINTEROS HD; VERON R; REY SO
    Prensa Med Argent; 1964 Oct; 51():876-7. PubMed ID: 14231392
    [No Abstract]   [Full Text] [Related]  

  • 56. Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.
    Monte AP; Marona-Lewicka D; Kanthasamy A; Sanders-Bush E; Nichols DE
    J Med Chem; 1995 Mar; 38(6):958-66. PubMed ID: 7699712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.
    Pettibone DJ; Pflueger AB
    J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.
    DOEPFNER W; CERLETTI A
    Int Arch Allergy Appl Immunol; 1958; 12(1-2):89-97. PubMed ID: 13549054
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE; Borsy J; Balogh T
    Acta Pharm Hung; 1973 Sep; 43(5):200-6. PubMed ID: 4755753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.